FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 320:684-688 March 16, 1989 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We analyzed the clinical courses of 94 patients with treated primary hypertension and initially normal serum creatinine concentrations (less than or equal to 133 mumol per liter [less than or equal to 1.5 mg per deciliter]) who were followed for a mean (+/- SD) of 58 +/- 34 months (range, 12 to 174) to determine the frequency with which renal function deteriorated and the factors associated with deterioration. Fourteen patients (15 percent) had an increase in serum creatinine concentrations (greater than or equal to 35 mumol per liter [greater than or equal to 0.4 mg per deciliter]); in 16 percent of the 61 patients with apparently good control of blood pressure, the serum creatinine concentration rose 59 +/- 33 mumol per liter (0.67 +/- 0.38 mg per deciliter). Despite good control of diastolic blood pressure (less than or equal to 90 mm Hg), black patients were twice as likely as white patients to have elevations in serum creatinine (23 percent vs. 11 percent). Stepwise discriminant function analysis showed that a significant rise in the serum creatinine concentration was most likely to occur in association with older age, black race, a higher number of missed office visits, and employment as a laborer. We conclude that although renal function was preserved in 85 percent of patients with treated hypertension, it may deteriorate in some patients despite good blood-pressure control. Our observations may partly explain why hypertension, particularly among black persons, remains a leading cause of renal disease in the United States.

Source Information

Nephrology Research and Training Center, University of Alabama, Birmingham 35294.

This article has been cited by other articles:

• Appel, L. J., Wright, J. T. Jr, Greene, T., Kusek, J. W., Lewis, J. B., Wang, X., Lipkowitz, M. S., Norris, K. C., Bakris, G. L., Rahman, M., Contreras, G., Rostand, S. G., Kopple, J. D., Gabbai, F. B., Schulman, G. I., Gassman, J. J., Charleston, J., Agodoa, L. Y., for the African American Study of Kidney Disease a, (2008). Long-term Effects of Renin-Angiotensin System-Blocking Therapy and a Low Blood Pressure Goal on Progression of Hypertensive Chronic Kidney Disease in African Americans. Arch Intern Med 168: 832-839 [Abstract] [Full Text]  
• Jawa, A., Nachimuthu, S., Pendergrass, M., Asnani, S., Fonseca, V. (2006). Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy. J. Clin. Endocrinol. Metab. 91: 31-35 [Abstract] [Full Text]  
• CY, H., CE, M., J, D., AS, G., C, I., E, T., HC, C., M, L., S, R., ER, R., B, T., G, L., N, P., KL, G., Y, W., DA, K., B, J., D, H., P, B., V, P., N, R., C, F., I, R., M, C., M, R., E, d. H., H, B., SJ, B., M, Z., E, R., P, M., MA, S., J, M., H, K., S, S., CR, B., P, N., HP, H., BA, Y., J, Z., FJ, v. d. W. (2005). Which Comes First--Renal Dysfunction or High Blood Pressure?: Elevated Blood Pressure and Risk of End-Stage Renal Disease in Subjects without Baseline Kidney Disease. Arch Intern Med 165: 923-928, 2005. J. Am. Soc. Nephrol. 16: 2817-2820 [Full Text]  
• Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sanchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., Acosta, J. H. (2005). Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?. J. Am. Soc. Nephrol. 16: 1909-1919 [Abstract] [Full Text]  
• Segura, J., Campo, C., Gil, P., Roldan, C., Vigil, L., Rodicio, J. L., Ruilope, L. M. (2004). Development Of Chronic Kidney Disease and Cardiovascular Prognosis in Essential Hypertensive Patients. J. Am. Soc. Nephrol. 15: 1616-1622 [Abstract] [Full Text]  
• Vupputuri, S., Batuman, V., Muntner, P., Bazzano, L. A., Lefante, J. J., Whelton, P. K., He, J. (2003). Effect of Blood Pressure on Early Decline in Kidney Function Among Hypertensive Men. Hypertension 42: 1144-1149 [Abstract] [Full Text]  
• Gassman, J. J., Greene, T., Wright, J. T. Jr., Agodoa, L., Bakris, G., Beck, G. J., Douglas, J., Jamerson, K., Lewis, J., Kutner, M., Randall, O. S., Wang, S.-R. (2003). Design and Statistical Aspects of the African American Study of Kidney Disease and Hypertension (AASK). J. Am. Soc. Nephrol. 14: S154-165 [Abstract] [Full Text]  
• Vikse, B. E., Aasarod, K., Bostad, L., Iversen, B. M. (2003). Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant 18: 517-523 [Abstract] [Full Text]  
• Wright, J. T. Jr, Bakris, G., Greene, T., Agodoa, L. Y., Appel, L. J., Charleston, J., Cheek, D., Douglas-Baltimore, J. G., Gassman, J., Glassock, R., Hebert, L., Jamerson, K., Lewis, J., Phillips, R. A., Toto, R. D., Middleton, J. P., Rostand, S. G., for the African American Study of Kidney Disease a, (2002). Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial. JAMA 288: 2421-2431 [Abstract] [Full Text]  
• Young, J. H., Klag, M. J., Muntner, P., Whyte, J. L., Pahor, M., Coresh, J. (2002). Blood Pressure and Decline in Kidney Function: Findings from the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Soc. Nephrol. 13: 2776-2782 [Abstract] [Full Text]  
• Tarver-Carr, M. E., Powe, N. R., Eberhardt, M. S., LaVeist, T. A., Kington, R. S., Coresh, J., Brancati, F. L. (2002). Excess Risk of Chronic Kidney Disease among African-American versus White Subjects in the United States: A Population-Based Study of Potential Explanatory Factors. J. Am. Soc. Nephrol. 13: 2363-2370 [Abstract] [Full Text]  
• Ishida, K., Ishida, H., Narita, M., Sairenchi, T., Saito, Y., Fukutomi, H., Takahashi, H., Yamagata, K., Koyama, A. (2001). Factors affecting renal function in 119 985 adults over three years. QJM 94: 541-550 [Abstract] [Full Text]  
• RUILOPE, L. M., SALVETTI, A., JAMERSON, K., HANSSON, L., WARNOLD, I., WEDEL, H., ZANCHETTI, A. (2001). Renal Function and Intensive Lowering of Blood Pressure in Hypertensive Participants of the Hypertension Optimal Treatment (HOT) Study. J. Am. Soc. Nephrol. 12: 218-225 [Abstract] [Full Text]  
• Young, C. J., Gaston, R. S. (2000). Renal Transplantation in Black Americans. NEJM 343: 1545-1552 [Full Text]  
• Kotchen, T. A., Piering, A. W., Cowley, A. W., Grim, C. E., Gaudet, D., Hamet, P., Kaldunski, M. L., Kotchen, J. M., Roman, R. J. (2000). Glomerular Hyperfiltration in Hypertensive African Americans. Hypertension 35: 822-826 [Abstract] [Full Text]  
• Luke, R. G. (1999). Hypertensive nephrosclerosis: pathogenesis and prevalence : Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant 14: 2271-2278 [Full Text]  
• Rahman, M., Smith, M. C. (1998). Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach. Arch Intern Med 158: 1743-1752 [Abstract] [Full Text]  
• Powers, D. R., Wallin, J. D. (1998). End-stage Renal Disease in Specific Ethnic and Racial Groups: Risk Factors and Benefits of Antihypertensive Therapy. Arch Intern Med 158: 793-800 [Abstract] [Full Text]  
• Hayakawa, H., Coffee, K., Raij, L. (1997). Endothelial Dysfunction and Cardiorenal Injury in Experimental Salt-Sensitive Hypertension : Effects of Antihypertensive Therapy. Circulation 96: 2407-2413 [Abstract] [Full Text]  
• Hebert, L. A., Kusek, J. W., Greene, T., Agodoa, L. Y., Jones, C. A., Levey, A. S., Breyer, J. A., Faubert, P., Rolin, H. A., Wang, S.-R. (1997). Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and Whites. Hypertension 30: 428-435 [Abstract] [Full Text]  
• Capers, Q. IV, Laursen, J. B., Fukui, T., Rajagopalan, S., Mori, I., Lou, P., Freeman, B. A., Berrington, W. R., Griendling, K. K., Harrison, D. G., Runge, M. S., Alexander, R. W., Taylor, W. R. (1997). Vascular Thrombin Receptor Regulation in Hypertensive Rats. Circ. Res. 80: 838-844 [Abstract] [Full Text]  
• Pogue, V. A., Ellis, C., Michel, J., Francis, C. K. (1996). New Staging System of the Fifth Joint National Committee Report on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V) Alters Assessment of the Severity and Treatment of Hypertension. Hypertension 28: 713-718 [Abstract] [Full Text]  
• Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., Stamler, J. (1996). Blood Pressure and End-Stage Renal Disease in Men. NEJM 334: 13-18 [Abstract] [Full Text]  
• Dustan, H. P. (1995). Does Keloid Pathogenesis Hold the Key to Understanding Black/White Differences in Hypertension Severity?. Hypertension 26: 858-862 [Abstract] [Full Text]  
• Falkner, B., Kushner, H., Levison, S., Canessa, M. (1995). Albuminuria in Association With Insulin and Sodium-Lithium Countertransport in Young African Americans With Borderline Hypertension. Hypertension 25: 1315-1321 [Abstract] [Full Text]  
• (1989). SUCCESSFUL TREATMENT OF HYPERTENSION DOES NOT ALWAYS PREVENT RENAL INSUFFICIENCY. JWatch General 1989: 2-2 [Full Text]  
• Suthanthiran, M., Li, B., Song, J. O., Ding, R., Sharma, V. K., Schwartz, J. E., August, P. (2000). Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc. Natl. Acad. Sci. USA 97: 3479-3484 [Abstract] [Full Text]